Executive Director, Clinical Quality Assurance

About Aura Biosciences

Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for patients living with ocular cancers. Bel-sar represents an entirely novel approach to treating ocular cancers via its dual mechanisms of action of acute tumor necrosis and secondary anti-tumor immune activation. The Phase 3 registration study of Bel-sar in early choroidal melanoma, the largest patient segment of uveal melanoma, is fully enrolled, and earlier stage studies in metastases to the choroid and cancers of the ocular surface are ongoing. Aura's mission is to improve outcomes for patients living with ocular cancers by delivering a therapy that not only arrests tumor growth but also preserves vision and quality of life.

For more information, visit
aurabiosciences.com. Follow us on X, @AuraBiosciences, and visit us on LinkedIn.

Summary

The Executive Director, GCP Quality Assurance provides strategic and functional leadership for GCP Quality across Aura Biosciences’ clinical development portfolio. This leader is accountable for establishing and advancing a risk-based, inspection-ready Clinical Quality framework that supports global clinical development and ensures compliance with applicable regulations, ICH guidelines, company procedures, and industry standards.

The Executive Director serves as a senior Quality partner to Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, and other cross-functional leaders, providing independent quality oversight, risk assessment, and strategic guidance throughout the clinical development lifecycle. This role leads GCP inspection readiness and sponsor inspection activities, including FDA BIMO inspections, and provides quality oversight of CROs and other critical clinical partners.

The Executive Director is a member of appropriate cross-functional governance and clinical leadership forums and serves as a key Quality advisor to senior management on clinical quality risks, compliance, inspection readiness, and overall quality strategy.

Key Responsibilities

Clinical Quality Strategy & Leadership

• Develop and lead the GCP Quality strategy and quality framework supporting Aura’s clinical development portfolio, with particular focus on pivotal and late-stage programs.
• Establish and continuously improve a risk-based Clinical Quality Management System encompassing auditing, quality events, CAPA, issue management, training, vendor oversight, and continuous improvement.
• Provide independent Quality leadership and strategic counsel to Clinical Operations, Clinical Development, Regulatory Affairs, and other GCP functions on complex compliance and quality matters.
• Establish GCP quality objectives, metrics, and leading indicators and provide strategic quality reporting, including contributions to Quality Management Review and senior leadership governance.
• Identify emerging compliance and quality risks, assess their potential impact on clinical programs and regulatory submissions, and ensure appropriate escalation and remediation.
• Promote a culture of quality, accountability, and proactive risk management across clinical development.

Clinical Trial & CRO Quality Oversight

• Provide strategic Quality oversight of global CROs, investigators, vendors, and other external partners supporting clinical development.
• Establish risk-based qualification, oversight, monitoring, and ongoing performance assessment processes for GCP and GLP vendors, including Approved Vendor List governance.
• Partner with Clinical Operations to ensure appropriate oversight of critical vendors and effective management of quality and compliance risks.
• Provide Quality input into clinical development strategies, protocols, informed consent forms, Clinical Study Reports, and other key clinical documentation, as appropriate.
• Ensure significant quality events, audit findings, and compliance issues are appropriately investigated, risk assessed, remediated, and trended.

Auditing, Compliance & Quality Systems

• Lead the development and execution of a risk-based GCP audit strategy encompassing clinical systems, processes, investigator sites, CROs, vendors, and computerized systems, as applicable.
• Provide strategic oversight of audit observations, inspection findings, CAPAs, and remediation plans, ensuring actions are scientifically sound, risk-based, timely, and sustainable.
• Identify systemic compliance trends and quality risks and drive cross-functional remediation and continuous improvement.
• Provide senior-level oversight of root cause analysis, quality event management, CAPA effectiveness, and quality risk management.
• Ensure GCP procedures, training, and quality processes evolve in response to regulatory expectations, inspection experience, organizational changes, and emerging industry practices.

Inspection Readiness & Regulatory Inspections

• Own and lead the GCP Inspection Readiness strategy for Aura’s clinical development programs.
• Lead preparation for and hosting of FDA BIMO and other global regulatory inspections involving clinical operations and sponsor oversight.
• Establish inspection readiness governance, training, mock inspections, BIMO interview preparation, document readiness, and cross-functional response processes.
• Serve as the senior GCP Quality leader during regulatory inspections and provide strategic direction for inspection responses, commitments, and remediation.
• Partner with Regulatory Affairs and Clinical leadership to ensure consistent, timely, and high-quality responses to regulatory inquiries and inspection observations.

Cross-Functional & Executive Leadership

• Serve as the senior GCP Quality representative on appropriate clinical and cross-functional governance forums and provide an independent Quality perspective on program strategy and risk.
• Build strong partnerships with Clinical Operations, Clinical Development, Regulatory Affairs, Medical Affairs, Data Management, Pharmacovigilance, and other relevant functions.
• Influence senior leaders and functional stakeholders to prioritize and resolve significant quality and compliance risks.
• Escalate critical compliance risks, systemic issues, or inadequate remediation to executive management with clear assessment of business and regulatory impact and recommended actions.
• Represent Quality in strategic discussions with external partners, CROs, consultants, and other stakeholders.
• Provide leadership, coaching, and development to GCP Quality personnel and contribute to the broader development of the Quality organization.

Training & Continuous Improvement

• Establish the strategic approach for GCP training and compliance awareness across clinical development.
• Ensure training requirements are appropriately aligned with roles, regulatory expectations, process changes, audit findings, inspection experience, and emerging risks.
• Drive continuous improvement initiatives that strengthen clinical quality, simplify processes, and improve organizational effectiveness.

Broader Quality Leadership

• Partner with the Quality leadership team on enterprise-wide quality initiatives and provide GCP expertise to support an integrated Quality organization.
• Provide GCP Quality support to GMP and other Quality activities when appropriate to business needs.

Qualifications

• Bachelor’s degree in a life science or related field required; advanced degree preferred.
• 15+ years of progressive experience in GCP Quality Assurance within the pharmaceutical or biotechnology industry, including significant leadership experience supporting global clinical development.
• Demonstrated experience leading GCP Quality strategy for late-stage/pivotal clinical programs and preparing organizations for regulatory inspections.
• Extensive knowledge and practical application of GCP, ICH, FDA, and applicable international clinical research requirements, including ICH E6.
• Proven experience with global CRO and clinical vendor oversight, risk management, auditing, CAPA, quality systems, and inspection readiness.
• Demonstrated experience leading FDA BIMO and/or other global regulatory inspections.
• Strong understanding of drug and biologic development, clinical operations, and the regulatory development lifecycle; broad understanding of nonclinical and CMC/manufacturing processes and their relationship to overall product development.
• Strong executive presence with demonstrated ability to influence senior leaders and cross-functional stakeholders.
• Demonstrated ability to make sound, risk-based decisions in complex and rapidly changing environments.
• Ability to manage multiple strategic priorities and operate effectively with ambiguity and incomplete information.
• RQA-GCP certification and working knowledge of cGMP and GVP requirements are desirable; combination product experience preferred.
• Ability to travel domestically and internationally as required.

Leadership Attributes

• Strategic Quality Leader: Translates regulatory and clinical risks into clear quality strategies and business priorities.
• Executive Influencer: Builds credibility with senior leaders and effectively influences decisions without relying solely on organizational authority.
• Risk-Based Decision Maker: Applies sound judgment to prioritize risks and resources based on patient, data integrity, regulatory, and business impact.
• Inspection Leader: Creates organizational confidence and discipline before, during, and after regulatory inspections.
• Enterprise Mindset: Looks beyond functional boundaries and considers the impact of quality decisions across the product lifecycle.

Salary & Benefit Information

Salary Range: $240,000/yr - $305,000/yr

(Placement within the listed range depends on many factors including, but not limited to: geographic location, degree, years of experience, and internal company equity)

Health insurance with FULL premium coverage

401K with company match

Employee Stock Purchase Program (ESPP)

Unlimited paid time off (PTO)

Company-paid short & long-term disability insurance and life insurance